About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [467 citations: 1–100 of 445 articles]

Articles published in Prostate Cancer have been cited 467 times. The following is a list of the 445 articles that have cited the articles published in Prostate Cancer.

  • Andrew B. Rosenkrantz, and Samir S. Taneja, “Magnetic Resonance Sentinel Lymph Node Detection in Prostate Cancer,” Academic Radiology, 2015. View at Publisher · View at Google Scholar
  • Laura Van den Bergh, Steven Joniau, Karin Haustermans, Christophe M. Deroose, Sofie Isebaert, Raymond Oyen, Felix M. Mottaghy, Filip Ameye, Joost Berkers, Hendrik Van Poppel, and Evelyne Lerut, “Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement,” Acta Oncologica, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • None Sawada, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Shizuka Sasazuki, Manami Inoue, and Shoichiro Tsugane, “Fiber intake and risk of subsequent prostate cancer in Japanese men,” American Journal Of Clinical Nutrition, vol. 101, no. 1, pp. 118–125, 2015. View at Publisher · View at Google Scholar
  • Eben L. Rosenthal, Jason M. Warram, Kirby I. Bland, and Kurt R. Zinn, “The Status of Contemporary Image-Guided Modalities in Oncologic Surgery,” Annals of Surgery, vol. 261, no. 1, pp. 46–55, 2015. View at Publisher · View at Google Scholar
  • Yi Yang Liu, Po Hui Chiang, Yao Chi Chuang, Wei Ching Lee, Yuan Tso Cheng, and Hung Jen Wang, “Predictors of Prostate-Specific Antigen Biochemical Recurrence in Patients Undergoing Primary Whole-Gland Prostate Cryoablation,” Annals Of Surgical Oncology, vol. 22, no. 5, pp. 1612–1617, 2015. View at Publisher · View at Google Scholar
  • Yao Zhu, Hong-Kai Wang, Yuan-Yuan Qu, and Ding-Wei Ye, “Prostate cancer in East Asia: evolving trend over the last decade,” Asian Journal Of Andrology, vol. 17, no. 1, pp. 48–57, 2015. View at Publisher · View at Google Scholar
  • Victoria Hillerdal, and Magnus Essand, “Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer,” BioDrugs, 2015. View at Publisher · View at Google Scholar
  • Hua Xu, Meng-bo Hu, Pei-de Bai, Wen-hui Zhu, Sheng-hua Liu, Jun-yao Hou, Zu-quan Xiong, Qiang Ding, and Hao-wen Jiang, “Proinflammatory Cytokines in Prostate Cancer Development and Progression Promoted by High-Fat Diet,” BioMed Research International, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Yi-Chien Lu, Wen-Chin Weng, and Hsinyu Lee, “Functional Roles of Calreticulin in Cancer Biology,” BioMed Research International, vol. 2015, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Alexandre Peltier, Fouad Aoun, Marc Lemort, Félix Kwizera, Marianne Paesmans, and Roland Van Velthoven, “MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men,” BioMed Research International, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Philipp Mandel, Thomas Steuber, Sascha Ahyai, Maximilian Kriegmair, Jonas Schiffmann, Katharina Boehm, Hans Heinzer, Uwe Michl, Thorsten Schlomm, Alexander Haese, Hartwig Huland, Markus Graefen, and Derya Tilki, “Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria,” BJU International, 2015. View at Publisher · View at Google Scholar
  • Pao-Hwa Lin, William Aronson, and Stephen J. Freedland, “Nutrition, dietary interventions and prostate cancer: the latest evidence,” Bmc Medicine, vol. 13, 2015. View at Publisher · View at Google Scholar
  • Ilir Agalliu, Akin O Adebiyi, David W Lounsbury, Oluwafemi Popoola, Kola Jinadu, Olukemi Amodu, Suvam Paul, Adebola Adedimeji, Chioma Asuzu, Michael Asuzu, Olufemi J Ogunbiyi, Thomas Rohan, and Olayiwola B Shittu, “The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria,” BMC Public Health, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  • Robyn Banerjee, Sang-June Park, Erik Anderson, D. Jeffrey Demanes, Jason Wang, and Mitchell Kamrava, “From whole gland to hemigland to ultra-focal high-dose rate prostate brachytherapy: A dosimetric analysis,” Brachytherapy, 2015. View at Publisher · View at Google Scholar
  • Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, and Ahmedin Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, 2015. View at Publisher · View at Google Scholar
  • Hannah K. Weir, Trevor D. Thompson, Ashwini Soman, Bjørn Møller, and Steven Leadbetter, “The past, present, and future of cancer incidence in the United States: 1975 through 2020,” Cancer, 2015. View at Publisher · View at Google Scholar
  • Pierrick G.J. Fournier, Patricia Juárez, Guanglong Jiang, Gregory A. Clines, Maria Niewolna, Hun Soo Kim, Holly W. Walton, Xiang Hong Peng, Yunlong Liu, Khalid S. Mohammad, Clark D. Wells, John M. Chirgwin, and Theresa A. Guise, “The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone,” Cancer Cell, 2015. View at Publisher · View at Google Scholar
  • Michael Cheng, Li Zhang, Margaret Borok, Eric Chokunonga, Charles Dzamamala, Anne Korir, Henry R. Wabinga, Robert A. Hiatt, D. Max Parkin, and Katherine Van Loon, “The incidence of oesophageal cancer in Eastern Africa: Identification of a new geographic hot spot?,” Cancer Epidemiology, 2015. View at Publisher · View at Google Scholar
  • Monica Cojoc, Claudia Peitzsch, Ina Kurth, Franziska Trautmann, Leoni A. Kunz-Schughart, Gennady D. Telegeev, Eduard A. Stakhovsky, John R. Walker, Karl Simin, Stephen Lyle, Susanne Fuesse, Kati Erdmann, Manfred P. Wirth, Mechthild Krause, Michael Baumann, and Anna Dubrovska, “Aldehyde Dehydrogenase Is Regulated by beta-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells,” Cancer Research, vol. 75, no. 7, pp. 1482–1494, 2015. View at Publisher · View at Google Scholar
  • Shanliang Zhong, Xiaohui Zhang, Lin Chen, Tengfei Ma, Jinhai Tang, and Jianhua Zhao, “Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies,” Cancer Treatment Reviews, 2015. View at Publisher · View at Google Scholar
  • Corina E. Antal, Andrew M. Hudson, Emily Kang, Ciro Zanca, Christopher Wirth, Natalie L. Stephenson, Eleanor W. Trotter, Lisa L. Gallegos, Crispin J. Miller, Frank B. Furnari, Tony Hunter, John Brognard, and Alexandra C. Newton, “Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor,” Cell, 2015. View at Publisher · View at Google Scholar
  • Pier-Luc Clermont, Dong Lin, Francesco Crea, Rebecca Wu, Hui Xue, Yuwei Wang, Kelsie L Thu, Wan L Lam, Colin C Collins, Yuzhuo Wang, and Cheryl D Helgason, “Polycomb-mediated silencing in neuroendocrine prostate cancer,” Clinical Epigenetics, vol. 7, no. 1, 2015. View at Publisher · View at Google Scholar
  • Bistra Galunska, Daniela Gerova, Petar Kosev, Deyan Anakievski, and Alexander Hinev, “Serum 25-Hydroxy Vitamin D Levels in Bulgarian Patients with Prostate Cancer: a Pilot Study,” Clinical Laboratory, vol. 61, no. 3-4, pp. 329–335, 2015. View at Publisher · View at Google Scholar
  • Rhonda Arthur, Alejo Rodríguez-Vida, Giorgia Zadra, Henrik Møller, and Mieke Van Hemelrijck, “Serum lipids as markers of prostate cancer occurrence and prognosis?,” Clinical Lipidology, vol. 10, no. 2, pp. 145–165, 2015. View at Publisher · View at Google Scholar
  • Kirk M. Anderson, Maxx Gallegos, Ty T. Higuchi, and Brian J. Flynn, “Evaluation and Management of Rectourethral Fistulas After Prostate Cancer Treatment,” Current Bladder Dysfunction Reports, 2015. View at Publisher · View at Google Scholar
  • Jonathan A. Coleman, “Functional outcomes of partial prostate ablation and focal therapy,” Current Opinion in Urology, vol. 25, no. 3, pp. 220–224, 2015. View at Publisher · View at Google Scholar
  • V. Kasivisvanathan, T.T. Shah, I. Donaldson, A. Kanthabalan, C.M. Moore, M. Emberton, and H.U. Ahmed, “Fokale Therapie des Prostatakarzinoms,” Der Urologe, vol. 54, no. 2, pp. 202–209, 2015. View at Publisher · View at Google Scholar
  • C. Reviriego, “ARN-509 Androgen receptor signaling inhibitor Prostate cancer therapy,” Drugs Of The Future, vol. 40, no. 2, pp. 101–108, 2015. View at Publisher · View at Google Scholar
  • J. M. Devaney, S. Wang, P. Furbert-Harris, V. Apprey, M. Ittmann, B-D Wang, J. Olender, N. H. Lee, and B. Kwabi-Addo, “Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men,” Epigenetics, vol. 10, no. 4, pp. 319–328, 2015. View at Publisher · View at Google Scholar
  • Kazuhiro Ohwaki, Fumiyasu Endo, and Kazunori Hattori, “Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy,” European Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • Mohamed Jalloh, Frank Myers, Janet E. Cowan, Peter R. Carroll, and Matthew R. Cooperberg, “Racial Variation in Prostate Cancer Upgrading and Upstaging Among Men with Low-risk Clinical Characteristics,” European Urology, vol. 67, no. 3, pp. 451–457, 2015. View at Publisher · View at Google Scholar
  • Fred Saad, Neal Shore, Hendrik Van Poppel, Dana E. Rathkopf, Matthew R. Smith, Johann S. de Bono, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Peter F.A. Mulders, Paul Mainwaring, John D. Hainsworth, Tomasz M. Beer, Scott North, Yves Fradet, Thomas A. Griffin, Peter De Porre, Anil Londhe, Thian Kheoh, Eric J. Small, Howard I. Scher, Arturo Molina, and Charles J. Ryan, “Impact of Bone-targeted Therapies in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA-302,” European Urology, 2015. View at Publisher · View at Google Scholar
  • Yan Zhu, Chengshan Li, Aichen Su, Yuanye Wang, and Shengnian Zhou, “Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer's disease,” Experimental and Therapeutic Medicine, 2015. View at Publisher · View at Google Scholar
  • Alexandru Dan Grigore, Eshel Ben-Jacob, and Mary C. Farach-Carson, “Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?,” Frontiers in Oncology, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Kashyap Shatagopam, Hristos Z. Kaimakliotis, Liang Cheng, and Michael O. Koch, “Genitourinary small cell malignancies: prostate and bladder,” Future Oncology, vol. 11, no. 3, pp. 479–488, 2015. View at Publisher · View at Google Scholar
  • Michael J Hall, Karen J Ruth, David YT Chen, Laura M Gross, and Veda N Giri, “Interest in genomic SNP testing for prostate cancer risk: a pilot survey,” Hereditary Cancer in Clinical Practice, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • Stefania Clemente, Roberta Nigro, Caterina Oliviero, Chiara Marchioni, Marco Esposito, Francesca Romana Giglioli, Pietro Mancosu, Carmelo Marino, Serenella Russo, Michele Stasi, Lidia Strigari, Ivan Veronese, and Valeria Landoni, “Role of the Technical Aspects of Hypofractionated Radiation Therapy Treatment of Prostate Cancer: A Review,” International Journal of Radiation Oncology*Biology*Physics, vol. 91, no. 1, pp. 182–195, 2015. View at Publisher · View at Google Scholar
  • Jeffrey A. Kittel, Chandana A. Reddy, Kristin L. Smith, Kevin L. Stephans, Rahul D. Tendulkar, James Ulchaker, Kenneth Angermeier, Steven Campbell, Andrew Stephenson, Eric A. Klein, D. Allan Wilkinson, and Jay P. Ciezki, “Long-Term Efficacy and Toxicity of Low-Dose-Rate 125I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer,” International Journal of Radiation Oncology*Biology*Physics, 2015. View at Publisher · View at Google Scholar
  • Yugo Sawada, Kazuya Omoto, Naoki Kohei, Kengo Sakaguchi, Masahiko Miura, and Kazunari Tanabe, “Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer,” International Journal of Urology, 2015. View at Publisher · View at Google Scholar
  • Xiaopeng Jia, Yanan Sun, and Baozhi Wang, “Gray level entropy matrix is a superior predictor than multiplex ELISA in the detection of reactive stroma and metastatic potential of high-grade prostatic adenocarcinoma,” IUBMB Life, 2015. View at Publisher · View at Google Scholar
  • Kei Sasaki, Hirofumi Miyata, Hiroto Sasaki, Siu Kang, Tetsuya Yuasa, and Ryuji Kato, “Image-based focused counting of dividing cells for non-invasive monitoring of regenerative medicine products,” Journal of Bioscience and Bioengineering, 2015. View at Publisher · View at Google Scholar
  • Linda Fleisher, Stacy N. Davis, Laura Gross, Loretta Bagden, Debra Zakrzewski, Evelyn González, Venk Kandadai, Cheryl Rusten, Jerilyn Baskett, Elias Obeid, and Veda N. Giri, “Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project,” Journal of Cancer Education, 2015. View at Publisher · View at Google Scholar
  • Olakanmi Ralph Akinde, Adekoyejo Abiodun Phillips, Olubanji Ajibola Oguntunde, and Olatunji Michael Afolayan, “Cancer Mortality Pattern in Lagos University Teaching Hospital, Lagos, Nigeria,” Journal of Cancer Epidemiology, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Matthew D. Christensen, Jacob J. Elmer, Seron Eaton, Laura Gonzalez-Malerva, Joshua LaBaer, and Kaushal Rege, “Kinome-level screening identifies inhibition of polo-like kinase-1 (PLK1) as a target for enhancing non-viral transgene expression,” Journal of Controlled Release, vol. 204, pp. 20–29, 2015. View at Publisher · View at Google Scholar
  • Yuan-Qing Fu, Ju-Sheng Zheng, Bo Yang, and Duo Li, “Effect of Individual Omega-3 Fatty Acids on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Stu,” Journal Of Epidemiology, vol. 25, no. 4, pp. 261–274, 2015. View at Publisher · View at Google Scholar
  • Shea William Wilcox, Noel J. Aherne, Craig Steven McLachlan, Michael J. McKay, Andrew J. Last, and Thomas P. Shakespeare, “Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: A comparison of Australian series,” Journal of Medical Imaging and Radiation Oncology, 2015. View at Publisher · View at Google Scholar
  • Jan Tykvart, Jiri Schimer, Andrej Jancarik, Jitka Barinkova, Vaclav Navratil, Jana Starkova, Karolina Sramkova, Jan Konvalinka, Pavel Majer, and Pavel Sacha, “Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II,” Journal of Medicinal Chemistry, pp. 150429121122000, 2015. View at Publisher · View at Google Scholar
  • Won Park, “Radiotherapy for prostate cancer,” Journal of the Korean Medical Association, vol. 58, no. 1, pp. 21, 2015. View at Publisher · View at Google Scholar
  • Julie A. Rytlewski, M. Alejandra Aldon, Evan W. Lewis, and Laura J. Suggs, “Mechanisms of Tubulogenesis and Endothelial Phenotype Expression by MSCs,” Microvascular Research, 2015. View at Publisher · View at Google Scholar
  • Ryu Nakadate, Jumpei Arata, and Makoto Hashizume, “Next-generation robotic surgery - from the aspect of surgical robots developed by industry,” Minimally Invasive Therapy & Allied Technologies, vol. 24, no. 1, pp. 2–7, 2015. View at Publisher · View at Google Scholar
  • Lin Zhang, Shuping Yang, Xingcheng Chen, Seth Stauffer, Fang Yu, Subodh M. Lele, Kai Fu, Kaustubh Datta, Nicholas Palermo, Yuanhong Chen, and Jixin Dong, “The Hippo Pathway Effector YAP Regulates Motility, Invasion, and Castration-Resistant Growth of Prostate Cancer Cells,” Molecular And Cellular Biology, vol. 35, no. 8, pp. 1350–1362, 2015. View at Publisher · View at Google Scholar
  • Celine Zimmermann, Isabelle Stevant, Christelle Borel, Beatrice Conne, Jean-Luc Pitetti, Pierre Calvel, Henrik Kaessmann, Bernard Jegou, Frederic Chalmel, and Serge Nef, “Research Resource: The Dynamic Transcriptional Profile of Sertoli Cells During the Progression of Spermatogenesis,” Molecular Endocrinology, vol. 29, no. 4, pp. 627–642, 2015. View at Publisher · View at Google Scholar
  • Jean-Jacques Body, Sandra Casimiro, and Luís Costa, “Targeting bone metastases in prostate cancer: improving clinical outcome,” Nature Reviews Urology, 2015. View at Publisher · View at Google Scholar
  • Dominik D. Alexander, Julie K. Bassett, Douglas L. Weed, Erin Cernkovich Barrett, Heather Watson, and William Harris, “Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LCω-3PUFA) and Prostate Cancer,” Nutrition and Cancer, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Marina Gobbe Moschetta, Larissa Bazela Maschio, Bruna Victorasso Jardim-Perassi, Gabriela Bottaro Gelaleti, Juliana Ramos Lopes, Camila Leonel, Naiane Do Nascimento Goncalves, Livia Carvalho Ferreira, Gustavo Rodrigues Martins, Thaiz Perraz Borin, and Debora Aparecida Pires De Campos Zuccari, “Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1 alpha in canine malignant mammary tumors,” Oncology Reports, vol. 33, no. 5, pp. 2345–2353, 2015. View at Publisher · View at Google Scholar
  • Hemant K. Roy, Charles B. Brendler, Hariharan Subramanian, Di Zhang, Charles Maneval, John Chandler, Leah Bowen, Karen L. Kaul, Brian T. Helfand, Chi-Hsiung Wang, Margo Quinn, Jacqueline Petkewicz, Michael Paterakos, and Vadim Backman, “Nanocytological Field Carcinogenesis Detection to Mitigate Overdiagnosis of Prostate Cancer: A Proof of Concept Study,” Plos One, vol. 10, no. 2, 2015. View at Publisher · View at Google Scholar
  • Anna C. Jones, Kresta S. Antillon, Shannon M. Jenkins, Sara N. Janos, Heidi N. Overton, Dor S. Shoshan, Edgar G. Fischer, Kristina A. Trujillo, and Marco Bisoffi, “Prostate Field Cancerization: Deregulated Expression of Macrophage Inhibitory Cytokine 1 (MIC-1) and Platelet Derived Growth Factor A (PDGF-A) in Tumo,” Plos One, vol. 10, no. 3, 2015. View at Publisher · View at Google Scholar
  • Brittany L. Mihelich, Joseph C. Maranville, Rosalie Nolley, Donna M. Peehl, and Larisa Nonn, “Elevated Serum MicroRNA Levels Associate with Absence of High-Grade Prostate Cancer in a Retrospective Cohort,” Plos One, vol. 10, no. 4, 2015. View at Publisher · View at Google Scholar
  • Sheen Cherian, Jeffrey A. Kittel, Chandana A. Reddy, Matthew D. Kolar, James Ulchaker, Kenneth Angermeier, Kevin L. Stephans, Rahul D. Tendulkar, Eric Klein, and Jay P. Ciezki, “Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis,” Practical Radiation Oncology, 2015. View at Publisher · View at Google Scholar
  • L C Macleod, L J Chery, E Y C Hu, S B Zeliadt, S K Holt, D W Lin, M P Porter, J L Gore, and J L Wright, “Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort,” Prostate Cancer and Prostatic Disease, 2015. View at Publisher · View at Google Scholar
  • Tracey Ledoux, Heather Adamus-Leach, Daniel P. O'Connor, Scherezade Mama, and Rebecca E. Lee, “The association of binge eating and neighbourhood fast-food restaurant availability on diet and weight status,” Public Health Nutrition, vol. 18, no. 2, pp. 352–360, 2015. View at Publisher · View at Google Scholar
  • Eamonn O’Leary, Frances J. Drummond, Anna Gavin, Heather Kinnear, and Linda Sharp, “Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate’s egg,” Quality of Life Research, 2015. View at Publisher · View at Google Scholar
  • J.R. Chícharo de Freitas, G.H. KleinJan, H.G. van der Poel, N.S. van den Berg, E. Vegt, M.P. Stokkel, and R.A. Valdés Olmos, “Utility of SPECT/CT scan for anatomical localization of pararectal and presacral sentinel nodes in prostate cancer,” Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), vol. 34, no. 1, pp. 19–23, 2015. View at Publisher · View at Google Scholar
  • O. E. Mustafina, I. A. Tuktarova, D. D. Karimov, R. Sh. Somova, and T. R. Nasibullin, “CYP2D6, CYP3A5, and CYP3A4 gene polymorphisms in Russian, Tatar, and Bashkir populations,” Russian Journal of Genetics, vol. 51, no. 1, pp. 98–107, 2015. View at Publisher · View at Google Scholar
  • E. Singh, J. M. Underwood, C. Nattey, C. Babb, M. Sengayi, and P. Kellett, “South African National Cancer Registry: Effect of withheld data from private health systems on cancer incidence estimates,” Samj South African Medical Journal, vol. 105, no. 2, pp. 107–109, 2015. View at Publisher · View at Google Scholar
  • Frederik Birkebæk Thomsen, Kasper Drimer Berg, Peter Iversen, and Klaus Brasso, “Poor association between the progression criteria in active surveillance and subsequent histopathological findings following radical prostatectomy,” Scandinavian Journal of Urology, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Amy L. Strong, Matthew E. Burow, Jeffrey M. Gimble, and Bruce A. Bunnell, “Concise Review: The Obesity Cancer Paradigm: Exploration of the Interactions and Crosstalk with Adipose Stem Cells,” Stem Cells, vol. 33, no. 2, pp. 318–326, 2015. View at Publisher · View at Google Scholar
  • Hayato Urushima, Yukiko Inomata-Kurashiki, Kazuo Nishimura, Ryoko Sumi, Iichiro Shimomura, Norio Nonomura, Toshinori Ito, and Kazuhisa Maeda, “The effects of androgen deprivation therapy with weight management on serum aP2 and adiponectin levels in prostate cancer patients,” The Aging Male, pp. 1–5, 2015. View at Publisher · View at Google Scholar
  • Almudena Zapatero, Araceli Guerrero, Xavier Maldonado, Ana Alvarez, Carmen Gonzalez San Segundo, Maria Angeles Cabeza Rodríguez, Victor Macias, Agustí Pedro Olive, Francesc Casas, Ana Boladeras, Carmen Martín de Vidales, Maria Luisa Vazquez de la Torre, Salvador Villà, Aitor Perez de la Haza, and Felipe A Calvo, “High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial,” The Lancet Oncology, 2015. View at Publisher · View at Google Scholar
  • Xinyu Yang, M. Francesca Monn, Libo Liu, Yuli Liu, Jinwei Su, Tianjing Lyu, Yanqing Gong, Lisha Wang, Darrell D. Davidson, and Liang Cheng, “Incidental prostate cancer in Asian men: High prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Henrique J. Cardoso, Cátia V. Vaz, Sara Correia, Marília I. Figueira, Ricardo Marques, Cláudio J. Maia, and Sílvia Socorro, “Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Roque Diaz, Paul A. Nguewa, Miriam Redrado, Irene Manrique, and Alfonso Calvo, “Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Seyed Hamid Aghaee-Bakhtiari, Ehsan Arefian, Mahmood Naderi, Farshid Noorbakhsh, Vahideh Nodouzi, Mojgan Asgari, Pezhman Fard-Esfahani, Reza Mahdian, and Masoud Soleimani, “MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • D. Baumunk, and M. Schostak, “Treatment of localized prostate cancer with high-intensity focused ultrasound,” Urologe, vol. 54, no. 2, pp. 183–190, 2015. View at Publisher · View at Google Scholar
  • Xiao Shen, and Wei-Qin Li, “High-mobility group box 1 protein and its role in severe acute pancreatitis,” World Journal Of Gastroenterology, vol. 21, no. 5, pp. 1424–1435, 2015. View at Publisher · View at Google Scholar
  • Jonas Busch, Mark L. Gonzalgo, Natalia Leva, Michelle Ferrari, Hannes Cash, Carsten Kempkensteffen, Stefan Hinz, Kurt Miller, and Ahmed Magheli, “Matched comparison of robotaEuroassisted, laparoscopic and open radical prostatectomy regarding pathologic and oncologic outcomes in obese patients,” World Journal Of Urology, vol. 33, no. 3, pp. 397–402, 2015. View at Publisher · View at Google Scholar
  • G. A. Gomez, P. F. Gutierrez, R. Lopez-Cubillana, and P. Lopez, “Is minimally invasive transanal surgery an alternative for rectal-urinary fistula correction?,” Actas Urologicas Espanolas, vol. 38, no. 4, pp. 276–277, 2014. View at Publisher · View at Google Scholar
  • Rose G. Radin, Shiriki K. Kumanyika, Edward A. Ruiz-Narvaez, Julie R. Palmer, and Lynn Rosenberg, “Prospective study of dietary fat and risk of uterine leiomyomata,” American Journal of Clinical Nutrition, vol. 99, no. 5, pp. 1105–1116, 2014. View at Publisher · View at Google Scholar
  • Youngyo Kim, and Youjin Je, “Dietary Fiber Intake and Total Mortality: A Meta-Analysis of Prospective Cohort Studies,” American Journal of Epidemiology, vol. 180, no. 6, pp. 565–573, 2014. View at Publisher · View at Google Scholar
  • Nathan A. Berger, “Obesity and cancer pathogenesis,” Annals of the New York Academy of Sciences, vol. 1311, no. 1, pp. 57–76, 2014. View at Publisher · View at Google Scholar
  • Edoardo Francini, Anna Ida Fiaschi, Roberto Petrioli, Filippo Francini, Vincenzo Bianco, Armando Perrella, Giovanni Paganini, Letizia Laera, and Giandomenico Roviello, “Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer,” Anti-Cancer Drugs, vol. 25, no. 4, pp. 472–477, 2014. View at Publisher · View at Google Scholar
  • Helen Blanchard, Khuchtumur Bum-Erdene, and Matthew W. Hugo, “Inhibitors of Galectins and Implications for Structure-Based Design of Galectin-Specific Therapeutics,” Australian Journal of Chemistry, vol. 67, no. 12, pp. 1763, 2014. View at Publisher · View at Google Scholar
  • Er-Jiang Lin, Xian Zhang, Da-Ya Wang, Shi-Zhe Hong, and Lei-Yu Li, “Naringenin modulates the metastasis of human prostate cancer cells by down regulating the matrix metalloproteinases-2/-9 via ROS/ERK1/2 pathways,” Bangladesh Journal of Pharmacology, vol. 9, no. 3, pp. 419–427, 2014. View at Publisher · View at Google Scholar
  • Katsura Kakoki, Haruka Kamiyama, Mai Izumida, Yuka Yashima, Hideki Hayashi, Naoki Yamamoto, Toshifumi Matsuyama, Tsukasa Igawa, Hideki Sakai, and Yoshinao Kubo, “Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Apollo D. Kacsinta, Cynthia S. Rubenstein, Isis C. Sroka, Sangita Pawar, Jaime M. Gard, Raymond B. Nagle, and Anne E. Cress, “Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Siegfried Wagner, Anaclet Ngezahayo, Hugo Murua Escobar, and Ingo Nolte, “ Role of miRNA Let-7 and Its Major Targets in Prostate Cancer ,” BioMed Research International, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Adam M. Hirst, Fiona M. Frame, Norman J. Maitland, and Deborah O’Connell, “Low Temperature Plasma: A Novel Focal Therapy for Localized Prostate Cancer?,” BioMed Research International, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Jan Tykvart, Jiří Schimer, Jitka Bařinková, Petr Pachl, Lenka Poštová-Slavětínská, Pavel Majer, Jan Konvalinka, and Pavel Šácha, “Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery,” Bioorganic & Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Andrea R. Spence, Marie-Claude Rousseau, Pierre I. Karakiewicz, and Marie-Élise Parent, “Circumcision and prostate cancer: a population-based case-control study in Montréal, Canada,” BJU International, 2014. View at Publisher · View at Google Scholar
  • Gillian M. Duchesne, and Henry H. Woo, “The ‘Timing of Androgen-Deprivation therapy in incurable prostate cancer’ protocol (TOAD) - where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial,” BJU International, vol. 114, pp. 9–12, 2014. View at Publisher · View at Google Scholar
  • Guru Sonpavde, Christopher G. Wang, Matthew D. Galsky, William K. Oh, and Andrew J. Armstrong, “Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC),” BJU International, 2014. View at Publisher · View at Google Scholar
  • Haidar Abdul-Muhsin, Camilo Giedelman, Srinivas Samavedi, Oscar Schatloff, Rafael Coelho, Bernardo Rocco, Kenneth Palmer, George Ebra, and Vipul Patel, “Perioperative and early oncological outcomes after robot-assisted radical prostatectomy (RARP) in morbidly obese patients: a propensity score-matched ,” Bju International, vol. 113, no. 1, pp. 84–91, 2014. View at Publisher · View at Google Scholar
  • Ying Zhang, Thomas Perez, Beth Blondin, Jing Du, Ping Liu, Diana Escarzaga, John S. Coon, Larry E. Morrison, and Katerina Pestova, “Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Elina Korpela, Darren Yohan, Lee C. L. Chin, Anthony Kim, Xiaoyong Huang, Shachar Sade, Paul Van Slyke, Daniel J. Dumont, and Stanley K. Liu, “Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Morten Beck Rye, Helena Bertilsson, Finn Drablos, Anders Angelsen, Tone F. Bathen, and May-Britt Tessem, “Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer,” Bmc Medical Genomics, vol. 7, 2014. View at Publisher · View at Google Scholar
  • Sigve Andersen, Elin Richardsen, Yngve Nordby, Nora Ness, Oystein Storkersen, Khalid Al-Shibli, Tom Donnem, Helena Bertilsson, Lill-Tove Busund, Anders Angelsen, and Roy M. Bremnes, “Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time,” Bmc Urology, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Kelvin A. Moses, Ling Y. Chen, Daniel D. Sjoberg, Melanie Bernstein, and Karim A. Touijer, “Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy,” Bmc Urology, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Brandon A. Mahal, David R. Ziehr, Andrew S. Hyatt, Emily H. Neubauer-Sugar, Desmond A. O'Farrell, Michael P. O'Leary, Graeme S. Steele, Thomas R. Niedermayr, Clair J. Beard, Neil E. Martin, Peter F. Orio, Anthony V. D'Amico, Phillip M. Devlin, and Paul L. Nguyen, “Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results,” Brachytherapy, 2014. View at Publisher · View at Google Scholar
  • Juanita Crook, “Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer,” Brachytherapy, 2014. View at Publisher · View at Google Scholar
  • A Paziewska, M Dabrowska, K Goryca, A Antoniewicz, J Dobruch, M Mikula, D Jarosz, L Zapala, A Borowka, and J Ostrowski, “DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy,” British Journal of Cancer, 2014. View at Publisher · View at Google Scholar